Literature DB >> 11786970

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Javier Fernández1, Miquel Navasa, Juliá Gómez, Jordi Colmenero, Jordi Vila, Vicente Arroyo, Juan Rodés.   

Abstract

The extensive use of invasive procedures and of long-term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis. We conducted a prospective evaluation of all bacterial infections diagnosed in patients with cirrhosis in a Liver Unit between April 1998 and April 2000. A total of 405 patients presented 572 bacterial infections in 507 admissions. Spontaneous bacterial peritonitis was the most frequent infection (138 cases). Gram-positive cocci were responsible for 53% of total bacterial infections in the study, being the main bacteria isolated in nosocomial infections (59%). Patients requiring treatment in an intensive care unit and those submitted to invasive procedures presented a higher rate of infections caused by gram-positive cocci (77% vs. 48%, P <.001 and 58% vs. 40%, P <.02, respectively). Fifty percent of culture-positive spontaneous bacterial peritonitis in patients on long-term norfloxacin administration (n = 93) and 16% in patients not receiving this therapy (n = 414) were caused by quinolone-resistant gram-negative bacilli, P =.01. The rate of culture-positive spontaneous bacterial peritonitis caused by trimethoprim-sulfamethoxazole-resistant gram-negative bacilli was also very high in patients on long-term norfloxacin administration (44% vs. 18%, P =.09). In conclusion, infections caused by gram-positive cocci have markedly increased in cirrhosis. This phenomenon may be related to the current high degree of instrumentation of cirrhotic patients. Quinolone-resistant spontaneous bacterial peritonitis constitutes an emergent problem in patients on long-term norfloxacin prophylaxis, with trimethoprim-sulfamethoxazole not being a valid alternative.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786970     DOI: 10.1053/jhep.2002.30082

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  230 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

2.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

3.  Prevalence and risk factors for unsuspected spontaneous ascitic fluid infection in cirrhotics undergoing therapeutic paracentesis in an outpatient clinic.

Authors:  Pazhanivel Mohan; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2011-09-29

Review 4.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

5.  Impaired lymphocyte reactivity measured by immune function testing in untransplanted patients with cirrhosis.

Authors:  Russell M Yee; Mandeep S Lehil; Catherine Rongey; Hui Shen; Myrna L Cozen; Alexander Monto; James C Ryan
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

Review 6.  Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding.

Authors:  Yeong Yeh Lee; Hoi-Poh Tee; Sanjiv Mahadeva
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies.

Authors:  Jennifer Chaulk; Michelle Carbonneau; Hina Qamar; Adam Keough; Hsiu-Ju Chang; Mang Ma; Deepali Kumar; Puneeta Tandon
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-28

Review 8.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

9.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27

Review 10.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.

Authors:  Sharad Sharma; Ahmet Gurakar; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2007-11-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.